Trevi Therapeutics (TRVI) EPS (Basic) (2018 - 2026)
Trevi Therapeutics' (TRVI) quarterly EPS (Basic) came in at -$0.09 in Q1 2026, down 3.06% year-on-year from -$0.09 in Q1 2025, and down 46.91% quarter-over-quarter from -$0.06 in Q4 2025.
Trevi Therapeutics (TRVI) EPS (Basic) (2018 - 2026) Analysis & Trends
Trevi Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.09 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 3.06% year-over-year to -$0.09 in Q1 2026; TTM through Mar 2026 was -$0.31, a 22.11% increase from a year earlier, with the FY2025 full-year figure at -$0.32, up 32.4% from the prior year.
- EPS (Basic) declined to -$0.09 in Q1 2026 per TRVI's latest filing, from -$0.06 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.06 in Q4 2025 and bottomed at -$0.24 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.09 (2026), against an average of -$0.1.
- Across the five-year window, EPS (Basic) jumped 77.13% in 2022 and plunged 68.87% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.09 in 2022, then climbed by 7.41% to -$0.08 in 2023, then slumped by 41.1% to -$0.11 in 2024, then soared by 44.65% to -$0.06 in 2025, then plunged by 46.91% to -$0.09 in 2026.
- Per Business Quant, the three latest TRVI EPS (Basic) figures stand at -$0.09 (Q1 2026), -$0.06 (Q4 2025), and -$0.08 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Trevi Therapeutics | 2.54 Bn | 2.54 Bn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | -0.06 |
| Sep 30, 2025 | -0.08 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.09 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -0.12 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -0.08 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.07 |
| Mar 31, 2023 | -0.06 |
| Dec 31, 2022 | -0.09 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.37 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.49 |